Revvity
David Sauze currently serves as Sr. Manager of Global Commercial Technology Strategy & Operations at Revvity since May 2023. Prior to this role, David held similar managerial positions at PerkinElmer, Inc. from January 2018 to May 2023, leading global commercial technology initiatives and overseeing diagnostic sales operations in EMEA. David's career also includes a significant tenure at Thermo Fisher Scientific, where responsibilities included managing forecasting and planning for the DACH region, and implementing analytics to support commercial leaders in South West Europe. Earlier experiences include sales administration management at DB Schenker-Joyau and marketing management at TRANSFLO, along with consultancy roles aimed at business development. David holds an MBA in Business Administration from the University of North Florida and a Bachelor's degree in International Business & Marketing from Ecole de Gestion et de Commerce de la Vendée.
This person is not in any teams
This person is not in any offices
Revvity
9 followers
At Revvity, “impossible” is inspiration, and ""can't be done"" is a call to action. Revvity provides health science solutions, technologies, expertise and services that deliver complete workflows from discovery to development, and diagnosis to cure. Revvity is revolutionizing what’s possible in healthcare, with specialized focus areas in translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection and diagnosis, informatics and more. With more than $3 billion in revenue and over 11,000 employees, Revvity serves customers across pharmaceutical and biotech, diagnostic labs, academia and governments. It is part of the S&P 500 index and has customers in more than 190 countries. Learn more at www.revvity.com